NCT01485445View on ClinicalTrials.gov

Bioequivalence Study to Compare Fluticasone Furoate (FF) 1-strip Inhaler With FF 2-strip Inhaler and With FF/Vilanterol Combination

PHASE1CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

December 21, 2011

Primary Completion Date

March 12, 2012

Study Completion Date

March 12, 2012

Conditions
Asthma
Interventions
DRUG

Fluticasone Furoate (200mcg unit strength)

inhalation powder

DRUG

Fluticasone Furoate/Vilanterol (200/25mcg unit strength)

inhalation powder

Trial Locations (1)

14050

GSK Investigational Site, Berlin

Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY

NCT01485445 - Bioequivalence Study to Compare Fluticasone Furoate (FF) 1-strip Inhaler With FF 2-strip Inhaler and With FF/Vilanterol Combination | Biotech Hunter | Biotech Hunter